Transcranial Magnetic Stimulation for Treatment-Resistant Depression (ePoster)
TMS is an effective alternative therapy for patients with TRD. Literature indicates that approximately 68% TRD patients went into remission after completing TMS sessions, while about 70% obtained significant symptom relief. TMS is safe, economical, and presents a durable antidepressant effect. It has no metabolic side effects and is a potential therapy for other psychiatric disorders.
Transcranial magnetic stimulation (TMS) is an effective therapy for resistant depression. It causes durable symptom remission.
|Release Date:||November 5, 2021|
|Expiration Date:||November 5, 2022|
|Credits Offered:||0.50 CE; includes 0.00 pharmacology credit|
Obtain Your Credits
To earn credits for this activity, you must 1) view the ePoster; 2) complete the ePoster evaluation; and 3) pass the post-test with a score of 2/3 (66.7%) or higher. You may retake the post-test until a passing score is achieved, at which point you will be able to view/print a copy of your certificate of completion. This online certificate will also be saved within your profile dashboard transcript for future access.
NPACE designates this educational activity for a maximum of 0.50 contact hours, of which 0.00 is pharmacology credit. Participants should claim only credit commensurate with the extent of their participation in the activity.
Nurse Practitioner Associates for Continuing Education (NPACE) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC).
In addition to ANCC, NPACE is approved as a provider of continuing education in nursing by: the California Board of Registered Nursing, Provider Number CEP8720 and Florida CE Broker #50-1476.
Contributing author, Raphael M. Bibiu, have disclosed no relevant financial relationships.
All planners and contributors involved in this educational activity have disclosed no relevant financial relationships.
The material presented in this continuing education program is being made available for educational purposes only and is not intended to represent the best or only methods, medications and/or guidelines appropriate for the medical situation discussed. Rather the material is intended to present an approach, view, statement, or opinion of the presenter(s), which may be helpful, or of interest to other practitioners and should not be used by clinicians without the evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. NPACE disclaims any liability, loss, injury, or damage incurred as a consequence, directly or indirectly, of the use and application of any information given in a presentation.
Disclosure of Unlabeled Use
This educational activity may mention the uses of products that are not approved by the FDA for the indication(s) being discussed. The presenter(s) are instructed to notify participants when they are discussing unapproved uses or investigational agents. The opinions related to unapproved uses of products are solely those of the presenter(s) and are not endorsed or recommended by NPACE. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
There is no commercial support for this activity.
|Access Date||Quiz Result||Score||Actions|